Medical News

Dual Antiplatelet Therapy in Ischemic Stroke or Transient Ischemic Attack Patients: What is the Optimal Duration?

The role of aspirin-clopidogrel (A+C) combination vs. aspirin monotherapy has not been elucidated completely in patients with acute ischemic stroke...

22 Apr, 2019

Email this page
Dimethyl Fumarate Versus Teriflunomide in Patients with Relapsing Remitting Multiple Sclerosis

Relapsing-remitting multiple sclerosis (RRMS) patients treated with dimethyl fumarate (DMF) experienced lower annualized relapse rate (ARR), higher...

18 Apr, 2019

Email this page
Higher Exposure to Air Pollutants Increases the Risk of Psychotic Experiences in Urban Youth

Youths exposed to air pollution—particularly nitrogen dioxide (NO2) and nitrogen oxides (NOx) have higher odds of adolescent psychotic experiences,...

12 Apr, 2019

Email this page
Sugar Rush: A Myth, Not Fact

Consumption of sugar-sweetened energy drinks is very common to cope up fatigue, and negative mood. But a recent systematic review and meta-analysis...

09 Apr, 2019

Email this page

Our Publications

DSM Dilemma: Issue 5

The current issue of  DSM dilemma attempts to give a comprehensive outlook on one of the important controversial revisions of DSM-5: changes in the...

DSM Dilemma: Issue 4

‘‘DSM Dilemma endeavors to bring to light DSM-5’s biggest changes and the possible impact they may have on mental health care. The fourth issue of...

DSM Dilemma: Issue 3

The current issue of DSM dilemma attempts to give a comprehensive outlook on one of the important criticism faced by DSM-5: over medicalising mental...

DSM Dilemma: Issue 2

The current issue of DSM Dilemma is a comprehensive guide of DSM-5 highlighting the major additions and revisions.

Key Trials

Dimethyl Fumarate Associated with better Work Productivity Outcomes Over β Interferon and Glatiramer Acetate Therapies in RRMS Patients

This novel study demonstrates better and sustained improvement in work productivity outcomes in relapse-remitting multiple sclerosis patients...

Dimethyl Fumarate Better than Teriflunomide and as Good as Fingolimod in MS

The study demonstrated that dimethyl fumarate is superior to teriflunomide in reducing the annual relapse rate and risk of relapse in multiple...

Delayed-Release Dimethyl Fumarate Favorably Impacts MRI Parameters in RRMS Patients with Sustained Benefits till 2 Years

The extended analysis of DEFINE trial demonstrates the favorable impact of delayed release DMF on various MRI parameters for up to 2 years.  

Oral Dimethyl Fumarate-A Potential Initial Treatment for Relapsing-Remitting Multiple Sclerosis

Oral dimethyl fumarate is a potential initial treatment for relapsing-remitting multiple sclerosis, as per the findings of the CONFIRM trial.  

Slide Library

Mental Health in Old Age

This slide set contains basic understanding of common mental health problems in old age, early warning signs and tips for better mental health care...

Email this page
Substance Abuse

This slide set discusses the issue of substance abuse in India with the risk factors, common reasons, early signs, and treatment of substance abuse...

Email this page
Attention Deficit Hyperactivity Disorder (ADHD)

This slide set contains general understanding of principal features, risk factors, and treatment for ADHD in children and adults.  

Email this page
Mental health

This slide set discusses the importance of mental health, factors contributing to mental health issues, and ways to maintain positive mental health...

Email this page


Do you think pre-hospital management of seizures improves overall seizure outcome?
100% (4 votes)
0% (0 votes)
Total votes: 4